Survival Benefits of Chemotherapy for Patients with Advanced Pancreatic Cancer in A Clinical Real-World Cohort

Clinical outcomes of chemotherapy for patients with advanced pancreatic adenocarcinoma in a real-world setting might differ from outcomes in randomized clinical trials (RCTs). Here we show in a single-institution cohort of 595 patients that median overall survival (OS) of patients who received gemci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kordes, Maximilian, Yu, Jingru, Malgerud, Oscar, Gustafsson Liljefors, Maria, Löhr, J. -Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769947/
https://www.ncbi.nlm.nih.gov/pubmed/31500236
http://dx.doi.org/10.3390/cancers11091326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769947/
https://www.ncbi.nlm.nih.gov/pubmed/31500236
http://dx.doi.org/10.3390/cancers11091326

Ejemplares similares